 | Up a level |
Berthold, Frank, Ernst, Angela 
ORCID: 0000-0003-2375-1889, Hero, Barbara, Klingebiel, Thomas, Kremens, Bernhard, Schilling, Freimut H. and Simon, Thorsten
(2018).
Long-term outcomes of the GPOH NB97 trial for children with high-risk neuroblastoma comparing high-dose chemotherapy with autologous stem cell transplantation and oral chemotherapy as consolidation.
Br. J. Cancer, 119 (3).
S. 282 - 291.
LONDON:
NATURE PUBLISHING GROUP.
ISSN 1532-1827
Berthold, Frank ORCID: 0000-0002-7613-1723, Rosswog, Carolina, Christiansen, Holger, Fruhwald, Michael, Hemstedt, Nadine, Klingebiel, Thomas, Frohlich, Birgit, Schilling, Freimut H., Schmid, Irene, Simon, Thorsten ORCID: 0000-0002-3425-8451, Hero, Barbara, Fischer, Matthias and Ernst, Angela ORCID: 0000-0003-2375-1889
(2021).
Clinical and molecular characterization of patients with stage 4(M) neuroblastoma aged less than 18 months without MYCN amplification.
Pediatr. Blood Cancer, 68 (8).
HOBOKEN:
WILEY.
ISSN 1545-5017
Berthold, Frank ORCID: 0000-0002-7613-1723, Spix, Claudia, Erttmann, Rudolf, Hero, Barbara, Michaelis, Joerg, Treuner, Joern, Ernst, Angela and Schilling, Freimut H.
(2021).
Neuroblastoma Screening at 1 Year of Age: The Final Results of a Controlled Trial.
JNCI Cancer Spectr., 5 (4).
OXFORD:
OXFORD UNIV PRESS.
ISSN 2515-5091
Spix, Claudia, Berthold, Frank, Hero, Barbara, Michaelis, Joerg and Schilling, Freimut H. (2016). Correction factors for self-selection when evaluating screening programmes. J. Med. Screen., 23 (1). S. 44 - 50. LONDON: SAGE PUBLICATIONS LTD. ISSN 1475-5793